BARRY S. TAUS

BARRY S. TAUS, graduated Cum Laude from the State University of New York at Albany in 1986 with a Bachelor of Science degree in Accounting.Mr. Taus joined the firm of Garwin, Bronzaft, Gerstein & Fisher in 1988, where he has worked on numerous antitrust and stockholder class action and derivative litigations. He graduated from Brooklyn Law School in 1989. Mr. Taus is admitted to the Bars of the State of New York and the United States District Court for the Southern District of New York. He is also a member of the Association of the Bar of the City of New York and the New York State Bar Association.

Mr. Taus is acting as Lead Counsel or Co-Lead Counsel in a number of major, complex antitrust litigations, including In re Cardizem CD Antitrust Litigation (E.D. Mich.); In re Terazosin Hydrochloride Antitrust Litigation (S.D. Fla.); In re Ciprofloxacin Hydrochloride Antitrust Litigation (E.D. N.Y.); and In re K-Dur Antitrust Litigation (D.N.J.) (Motion for Appointment as Co-Lead Counsel pending). Mr. Taus is also taking an active role in Louisiana Wholesale Drug Co., Inc. v. Bristol-Myers Squibb (S.D.N.Y.) in which his firm is Co-Lead Counsel. Mr. Taus had also taken a central, active role in many of the stockholder class action and derivative actions in which his firm has been Lead Counsel) (as detailed above), including Rebenstock v. Fruehauf (Fruehauf Trailer); In re Par Pharmaceutical Securities Litigation; In re F&M Distributors, Inc. Securities Litigation.